[
    {
        "question": "A case of gestational trophoblastic neoplasia is detected to have lung metastasis. She should be staged as:",
        "exp": "Ans. is c, i. e. Stage IIIRef. COGDT 10/e, p 893. Staging of Gestational trophoblastic disease: Stage-I Disease confined to uterus. Stage-II Disease extending outside of the uterus but limited to the genital structures (adnexa, vagina, broad ligaments). Stage-III Disease extending to the lungs, with or without known genital tract involvement. Stage-IV Disease at other metastatic sites viz brain, liver, kidney or gastrointestinal tract.",
        "cop": 3,
        "opa": "Stage-I",
        "opb": "Stage-II",
        "opc": "Stage-III",
        "opd": "Stage - IV",
        "subject_name": "Gynaecology & Obstetrics",
        "topic_name": "Gestational Trophoblastic Disease",
        "id": "0df9f346-27cf-44b8-8e0d-45d15e304fe9",
        "choice_type": "single"
    },
    {
        "question": "Which of the following is the most common cause of persistent trophoblastic disease after H. Mole evacuation?",
        "exp": "Ans. D. Residual Mole. Upto 20% of women with H. Mole show persistence of tumor in uterus following surgical evacuation. a. 15% persist as persistant or residual mole. b. 5% develop choriocarcinoma. c. Trophoblastic tumors diagnosed for upto 6 months following an abortion or mole is often. An invasive mole, but the one diagnosed after 6 months is usually choriocarcinoma. d. It is to be noted that trophoblastic tumor developing after a full-term pregnancy is always a choriocarcinoma.",
        "cop": 4,
        "opa": "Choriocarcinoma",
        "opb": "Invasive mole",
        "opc": "Placental site trophoblastic tumor",
        "opd": "Residual Mole",
        "subject_name": "Gynaecology & Obstetrics",
        "topic_name": "Gestational Trophoblastic Disease",
        "id": "98a6ba4c-f3a9-42b9-b282-63171a38b587",
        "choice_type": "single"
    },
    {
        "question": "A 40 years old P4+2 female has been diagnosed to have H mole. The treatment would be:",
        "exp": "Ans. is c, i. e. Total hysterectomy. Ref. Dutta Obs. 7/e, p 195; COGDT 10/e, p 889, William Obs. 23/e, p 261, 24/e, p 401\"If no further pregnancies are desired, hysterectomy may be preferred to suction curettage. It is a logical procedure in women aged 40 or older because atleast a third of these women will go on to develop gestational trophoblastic neoplasia. \" --William Obs 23/e, p 261. Remember: Hysterectomy only decreases the chances of malignancy in cases of hydatidiform mole and does not eliminate the necessity of follow-up.",
        "cop": 3,
        "opa": "Radiotherapy",
        "opb": "Chemotherapy",
        "opc": "Total hysterectomy",
        "opd": "Radio chemotherapy",
        "subject_name": "Gynaecology & Obstetrics",
        "topic_name": "Gestational Trophoblastic Disease",
        "id": "0ca248ee-2699-4002-9085-c040ecbdeb8b",
        "choice_type": "single"
    },
    {
        "question": "A female with H/O trophoblastic has ____% chances of developing trophoblastic disease in next pregnancy:",
        "exp": "Ans. is a, i. e. 2%Ref. Williams 24/e, p 404, Dutta Obs. 8/e, p 226. Friends: Remember both the values-specifically-risk of recurrence of trophoblastic disease in future pregnancies is 2% range is 1-4%",
        "cop": 1,
        "opa": "2%",
        "opb": "5%",
        "opc": "8-12%",
        "opd": "15-20%",
        "subject_name": "Gynaecology & Obstetrics",
        "topic_name": "Gestational Trophoblastic Disease",
        "id": "5077bbb1-e103-424d-9d36-ebbbeec10571",
        "choice_type": "single"
    },
    {
        "question": "Treatment of choice choriocarcinoma is:",
        "exp": "Ans. A. Chemotherapy* The treatment of choice of choriocarcinoma is mainly chemotherapy both for local and distal metastasis. The drug of choice for the same is methotrexate. It is given orally 5mg five times a day for 5 days. Side effects of Methotrexate are ulcerative stomatitis, gastric hemorrhage, skin reaction, alopecia, bone marrow suppression, Liver and Kidney damage.",
        "cop": 1,
        "opa": "Chemotherapy",
        "opb": "External beam radiotherapy",
        "opc": "Hysterectomy",
        "opd": "Intracavitary brachytherapy",
        "subject_name": "Gynaecology & Obstetrics",
        "topic_name": "Gestational Trophoblastic Disease",
        "id": "8d7482e4-4e96-427c-9bb6-d87a819e3e97",
        "choice_type": "single"
    },
    {
        "question": "The best investigation to diagnose carcinoma cervix in early stages:",
        "exp": "Ans. C. Pap smear. Pap smear is a screening test. It is the initial test in all patients unless a visible growth is present that needs to be biopsied. Colposcopy is also a screening test that is done in well-equipped centers. It is costly and needs more expertise. Aceto White lesion has many differentials ranging from leukoplakia, SIL, cancer, HPV infection to metaplasia. This technique is used in periphery where there is no facility of Pap smear and colposcopy to identify the high-risk cases. Hysteroscopy is for diagnosis of uterine lesion. Of the options listed here, Pap smear is the best answer.",
        "cop": 3,
        "opa": "Colposcopic biopsy",
        "opb": "Aceto White over lesion",
        "opc": "Pap smear",
        "opd": "Hysteroscopy",
        "subject_name": "Gynaecology & Obstetrics",
        "topic_name": "Gestational Trophoblastic Disease",
        "id": "8685bc41-2485-48ae-b3c3-5e0924539925",
        "choice_type": "single"
    },
    {
        "question": "Follow-up in a patient of H mole is done by:",
        "exp": "Ans. is a, i. e. Serum Beta h. CG monitoring. Ref. Dutta Obs. 7/e, p 195, 196; Novak 14/e, p 1590. The chances of persistent trophoblastic disease and choriocarcinoma are high after evacuation of H mole therefore regular follow-up is mandatory. \"After molar evacuation, patients should be monitored with weekly determinations of b-subunit h. CG levels until these levels are normal for 3 consecutive weeks, followed by monthly determinations until the levels are nomrmal for 6 consecutive months. The average time to achieve the first normal h. CG level after evacuation is about 9 weeks. At the completion of follow-up, pregnancy may be undertaken. After a patient achieves a nondetectable h. CG level, the risk of developing tumour relapse is very low and may approach zero. \" --Novak 14/e, p 1590",
        "cop": 1,
        "opa": "Serum Beta-h. CG monitoring",
        "opb": "Serum CEA level estimation",
        "opc": "Serum amylase level",
        "opd": "Serum a-fetoprotein estimation",
        "subject_name": "Gynaecology & Obstetrics",
        "topic_name": "Gestational Trophoblastic Disease",
        "id": "aec6bf02-51da-498e-a09c-8c787fca8fb8",
        "choice_type": "single"
    },
    {
        "question": "The ideal treatment for metastatic choriocarcinoma in the lungs in a young woman is:",
        "exp": "Ans. is a, i. e. Chemotherapy. Ref. Shaw 14/e, p 235; COGDT 10/e, p 892, 893\"Unlike other malignant lesion, the treatment of choriocarcinoma is mainly chemotherapy, both for local and distant metastasis. \" --Shaw 14/e, p 235",
        "cop": 1,
        "opa": "Chemotherapy",
        "opb": "Surgery with radiation",
        "opc": "Surgery",
        "opd": "Wait and watch",
        "subject_name": "Gynaecology & Obstetrics",
        "topic_name": "Gestational Trophoblastic Disease",
        "id": "55c8250f-a165-460e-8530-49d26b0134c6",
        "choice_type": "single"
    },
    {
        "question": "The following are related to prophylactic chemotherapy in molar pregnancy:",
        "exp": "Ans. is a, i. e. It may be given in 'at risk' patients. Ref. Dutta Obs. 7/e. p 196. Prophylactic chemotherapy in H mole. Is given only to high risk patients (as discussed earlier) and to not all patients following suction evaculation because these drugs are toxic and can increase the risk of premature ovarian failure and menopause. Monotherapy with methotrexate is prefered (not multiple agents). The use of prophylactic chemotherapy reduces the chances of developing choriocarcinoma but doest not make it nil.",
        "cop": 1,
        "opa": "It may be given in 'at risk' patients",
        "opb": "Multiple agents are preferred",
        "opc": "Malignant sequelae becomes nil",
        "opd": "Follow-up is not required",
        "subject_name": "Gynaecology & Obstetrics",
        "topic_name": "Gestational Trophoblastic Disease",
        "id": "4f7788e8-f304-4a29-adef-c9b64e00e25d",
        "choice_type": "single"
    },
    {
        "question": "A 22 years old female underwent suction evacuation for molar pregnancy. Beta HCG levels are persistently high following evacuation. The next line of management is:",
        "exp": "Ans. is d, i. e. Methotrexate. Persistently raised bh. CG levels after H mole evacuation indicate the patient may develop GTN, and is an indication for Prophylactic methotrexate therapy.",
        "cop": 4,
        "opa": "Follow up at 1 year",
        "opb": "Monitor until HCG becomes 0",
        "opc": "Hysterectomy",
        "opd": "Methotrexate",
        "subject_name": "Gynaecology & Obstetrics",
        "topic_name": "Gestational Trophoblastic Disease",
        "id": "3d9c7b70-4800-4dd5-adec-15cd530f81bf",
        "choice_type": "single"
    },
    {
        "question": "A 45 yrs old lady with DUB has 8 mm thick endometrial echo. What should be done for her?",
        "exp": "Ans. C. Histopathological examination of the curettage. In lady with DUB has 8mm thick endometrial echo, D&C should be done and Histopathological examination of the curettage should be awaited for planning the further management.",
        "cop": 3,
        "opa": "Hysterectomy",
        "opb": "Start Progesterone therapy",
        "opc": "Histopathological examination of the curettage",
        "opd": "Follow up sonography",
        "subject_name": "Gynaecology & Obstetrics",
        "topic_name": "Gestational Trophoblastic Disease",
        "id": "869bb71f-7529-4f8d-8f72-54b10cfd3e40",
        "choice_type": "single"
    },
    {
        "question": "Treatment of the lutein cyst in hydatidiform mole is:",
        "exp": "Ans. is c, i. e. Suction evacuation. Ref. COGDT 10/e, p 889. Management of theca lutein cysts: Theca lutein cysts are seen in H. mole due to high circulating levels of h. CG. As such they donot need any separate treatment. Suction evacuation of H mole results in diminishing h. CG titre, which leads to spontaneous regression of theca lutein cysts. \"Because theca lutein cysts regress following suction evacuation, expectant management is preferred\". --William 24/e, p 398",
        "cop": 3,
        "opa": "Ovarian cystectomy",
        "opb": "Ovariectomy",
        "opc": "Suction evacuation",
        "opd": "Ovariotomy",
        "subject_name": "Gynaecology & Obstetrics",
        "topic_name": "Gestational Trophoblastic Disease",
        "id": "c929188a-764f-4a36-93c2-cd37e668181b",
        "choice_type": "single"
    },
    {
        "question": "Choriocarcinoma with lung mets is satge-",
        "exp": "Ans. is 'b' i. e., 3 Stages of chorio carcinoma. Stage IDisease confined to uterus. Stage. IADisease confined to uterus with no risk factors. Stage IBDisease confined to uterus with one risk factor. Stage ICDisease confined to uterus with two risk factors. Stage IIGestational trophoblastic tumor extending outside uterus but limited to genital structures (adnexa, vagina, and broad ligament). Stage IIAGestational trophoblastic tumor extending outside uterus but limited to genital structures without risk factors. Stage I IBGestational trophoblastic tumor extending outside uterus but limited to genital structures with one risk factor. Stage IICGestational trophoblastic tumor extending outside uterus but limited to genital structures with two risk factors. Stage IIIGestational trophoblastic disease extending to lungs with or without known genital tract involvement. Stage IIIAGestational trophoblastic tumor extending to lungs with or without genital tract involvement and with no risk factors. Stage IIIBGestational trophoblastic tumor extending to lungs with or without genital tract involvement and with one risk factor. Stage IIICGestational trophoblastic tumors extending to lungs with or without genital tract involvement and with two risk factors. Stage IVAll other metastatic sites (liver/brain). Stage IVAAll other metastatic sites without risk factors. Stage IVBAll other metastatic sites with one risk factor. Stage IVCAll other metastatic sites with two risk factors",
        "cop": 2,
        "opa": "1",
        "opb": "3",
        "opc": "2",
        "opd": "4",
        "subject_name": "Gynaecology & Obstetrics",
        "topic_name": "Gestational Trophoblastic Disease",
        "id": "b71da162-f9d5-4d64-8508-d8b8df72e610",
        "choice_type": "single"
    },
    {
        "question": "EMA-CO regime of chemotherapy is used in the treatment of?",
        "exp": "Ans. A. Gestational trophoblastic neoplasia. Patients with high-risk tumors (high beta-h. CG levels, disease presenting >=4 months after antecedent pregnancy, brain or liver metastasis, or failure of single-agent methotrexate) are initially treated with combination chemotherapy. EMA-CO (a cyclic non-cross-resistant combination of etoposide, methotrexate, and dactinomycin alternating with cyclophosphamide and vincristine); cisplatin, bleomycin, and vinblastine; and cisplatin, etoposide, and bleomycin are effective regimens. EMA-CO is now the regimen of choice for patients with high-risk disease because of excellent survival rates (>80%) and less toxicity.",
        "cop": 1,
        "opa": "Gestational trophoblastic neoplasia",
        "opb": "Malignant Ovarian germ cell tumor",
        "opc": "Endometrial carcinoma",
        "opd": "CA cervix",
        "subject_name": "Gynaecology & Obstetrics",
        "topic_name": "Gestational Trophoblastic Disease",
        "id": "6e9a4af8-1f01-44cd-bc36-ad702ff8d035",
        "choice_type": "single"
    }
]